Oncology Resource Group (ONCrg) is a marketing startup founded in 2013 by Stacey McCann and Michael D. Reynolds. The company specializes in providing best-in-class competitive intelligence to pharmaceutical and biotechnology developers globally. ONCrg's expert advisors focus on solid tumor, hematologic malignancy, emerging and late-stage immuno-oncology, and MOA drug markets, delivering market planning and competitive intelligence reports.
The company's vision is to add value to client programs through focused expertise in oncology drug markets, providing deeper market planning resources than competitors who work in non-drug and non-oncology sectors. ONCrg is committed to helping clients create winning strategies and make informed business decisions for their new products, brands, franchises, partnerships, and alliances.
With an exclusive focus on oncology markets, ONCrg empowers talented consultants to achieve new standards of analytical excellence and deliver accurate, insightful, and robust market planning resources. The company aims to provide clients with the most relevant forward-looking resources in the challenging healthcare arena.
As of now, there is no available information on ONCrg's headquarters, last investment, or last investment investors.